Kori Johnson

Kori Johnson is a traffic anchor/reporter for WKRN News 2 in Nashville. She previously worked as an anchor and reporter for KSLA-TV in Shreveport, LA., and WCTI-TV in New Bern, NC.

43%

The Daily's Verdict

This author has a poor reputation for journalistic standards and is not considered a reliable news source.

Bias

50%

Examples:

  • The author seems to have a positive bias towards weight loss injectables and their benefits.

Conflicts of Interest

30%

Examples:

  • There is no clear conflict of interest disclosed in this article.

Contradictions

60%

Examples:

  • ,
  • The article contains several contradictions about the availability and safety of these drugs.

Deceptions

40%

Examples:

  • ,
  • The author uses vague terms like 'bad side effects' and 'adulterating' to describe the potential risks and practices associated with weight loss injectables.

Recent Articles

Botulism from Counterfeit Cosmetic Products in Tennessee: State Department of Health Investigates

Botulism from Counterfeit Cosmetic Products in Tennessee: State Department of Health Investigates

Broke On: Wednesday, 10 April 2024 Recent counterfeit cosmetic products have caused botulism in Tennessee, prompting an investigation by the state department of health and other agencies.
Botulism from Counterfeit Cosmetic Products in Tennessee: State Department of Health Investigates

Botulism from Counterfeit Cosmetic Products in Tennessee: State Department of Health Investigates

Broke On: Wednesday, 10 April 2024 Recent counterfeit cosmetic products have caused botulism in Tennessee, prompting an investigation by the state department of health and other agencies.
FDA Investigates Possible Side Effects from GLP-1 Drugs: Suicidal Ideation, Hair Loss and Aspiration

FDA Investigates Possible Side Effects from GLP-1 Drugs: Suicidal Ideation, Hair Loss and Aspiration

Broke On: Saturday, 13 January 2024 The FDA is investigating possible side effects from GLP-1 drugs, including suicidal ideation, hair loss and aspiration. These medications have become popular for both weight loss and type 2 diabetes treatment over the last year. A new study found no link between semaglutide, an active ingredient in GLP-1 drugs like Ozempic and Wegovy, and suicidal ideation but people taking these medications had a lower risk of suicidal thoughts compared with older drugs in U.S studies.